The present report presents evidence that operant conditioning processes may contribute to hypokinetic effects in rats induced by repeated haloperidol (HAL) treatments. Twenty-four male Sprague-Dawley rats were subdivided into three equal groups and given 9 daily injections of either 0.1 or 1.0 mg/kg HAL, i.p., or the lactic acid vehicle 1 h before testing of motoric behavior. The effects of the HAL were dependent upon dose and the test situation. In an open field, 1.0 HAL produced a complete akinesia whereas 0.1 HAL initially had no effect, but with repeated treatments the 0.1-HAL-treated rats became hypokinetic. When the animals were tested for their response to enter a dark compartment, the 2 doses had equivalent effects. Initially, HAL had no effect, but with repeated treatments, latencies to enter the dark compartment increased at the equivalent rates for the 0.1 and 1.0 HAL groups. When conditioned drug effects were assessed following withdrawal, only in drug environment situations which operant behavior occurred initially did hypokinesia persist. These results are relevant to understanding the delayed onset of action and antipsychotic effects of neuroleptic drugs.

Keywords:
Conditioning, Haloperidol, Hypokinesia, Operant behavior
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.